Welcome
Support Centre
26 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Therapeutic Assessment (TA) of adolescents presenting with self harm versus standard psychosocial assessment and risk management: a randomised controlled trial
ISRCTN ISRCTN81605131
DOI 10.1186/ISRCTN81605131
ClinicalTrials.gov identifier
EudraCT number
Public title Therapeutic Assessment (TA) of adolescents presenting with self harm versus standard psychosocial assessment and risk management: a randomised controlled trial
Scientific title
Acronym TA
Serial number at source 2
Study hypothesis Therapeutic Assessment (TA) versus assessment as usual will improve engagement with follow up.
Lay summary Not provided at time of registration
Ethics approval Ethics approval received from the Camden and Islington Community Local Research Ethics Committee on the 23rd October 2007 (ref: 07/H0722/66).
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Self harm
Participants - inclusion criteria 1. Aged 12 - 17 years (inclusive)
2. Presentation with self harm
3. Referral for a Child and Adolescent Mental Health Services (CAMHS) assessment
Participants - exclusion criteria 1. Poor English
2. Gross reality distortion due to psychosis or inebriation
3. Immediate risk of violence or suicide
4. Known moderate to severe learning disability
5. Admission to psychiatric in-patient unit
Anticipated start date 01/11/2007
Anticipated end date 01/11/2008
Status of trial Completed
Patient information material
Target number of participants 70
Interventions Therapeutic Assessment (TA) versus assessment as usual. There is no structured intervention after the initial assessment. This is a study of the assessment process. Participants will be followed up by relevant community teams and recommendations will be made about the optimal management.
Primary outcome measure(s) Engagement with follow up, measured at 3 and 6 months after the initial assessment.
Secondary outcome measure(s) 1. Measures of general and depressive symptomatology, measured at 3 and 6 months after the initial assessment
2. Service use and functioning, measured at 3 and 6 months after the initial assessment
Sources of funding 1. Maudsley Charitable Foundation (UK)
2. West London Research Consortium (UK)
Trial website
Publications 1. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/21030367
2. 2013 results in www.ncbi.nlm.nih.gov/pubmed/23709314
Contact name Dr  Dennis  Ougrin
  Address Snowsfields Adolescent Unit
York Clinic, Guy's Hospital
47 Weston St
  City/town London
  Zip/Postcode SE1 3RR
  Country United Kingdom
Sponsor South London and Maudsley NHS Trust (UK)
  Address Research & Development Office (P005), Room W108
Institute of Psychiatry, King's College London
De Crespigny Park
  City/town London
  Zip/Postcode SE5 8AF
  Country United Kingdom
  Tel +44 (0)20 7848 0675
  Fax +44 (0)20 7848 0147
  Email g.dale@iop.kcl.ac.uk
  Sponsor website: http://www.slam.nhs.uk/
Date applied 13/11/2007
Last edited 28/05/2013
Date ISRCTN assigned 07/12/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.